Information de reference pour ce titreAccession Number: | 01445389-201707000-00018.
|
Author: | Vieira de Melo, Rodrigo Morel MD, PhD 1; Hueb, Whady MD, PhD *,1; Nomura, Cesar Higa MD 1; Ribeiro da Silva, Expedito Eustaquio MD, PhD 1; Villa, Alexandre Volney MD 1; Oikawa, Fernando Teiichi Costa MD 1; da Costa, Leandro Menezes Alves MD 1; Rezende, Paulo Cury MD, PhD 1; Garzillo, Cibele Larrosa MD, PhD 1; Lima, Eduardo Gomes MD, PhD 1; Franchini Ramires, Jose Antonio MD, PhD 1; Kalil Filho, Roberto MD, PhD 1
|
Institution: | (1) Department of AtherosclerosisHeart Institute (InCor) of the University of Sao PauloSao Paulo SP Brazil
|
Title: | |
Source: | Catheterization & Cardiovascular Interventions. 90(1):87-93, July 1, 2017.
|
Author Keywords: | cardiac magnetic resonance imaging; coronary artery disease; percutaneous coronary intervention; troponin.
|
References: | 1. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 2005;26:2493-2519.
2. Roger VL, Killian JM, Weston SA, et al. Redefinition of myocardial infarction: Prospective evaluation in the community. Circulation 2006;114:790-797.
3. Lansky AJ, Stone GW. Periprocedural myocardial infarction: Prevalence, prognosis, and prevention. Circ Cardiovasc Interv 2010;3:602-610.
4. Lim CCS, van Gaal WJ, Testa L, et al. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention. J Am Coll Cardiol 2011;57:653-661.
5. Cuculi F, Lim CCS, Banning AP. Periprocedural myocardial injury during elective percutaneous coronary intervention: Is it important and how can it be prevented? Heart 2010;96:736-740.
6. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012;126:2020-2035.
7. Brener SJ, Ellis SG, Schneider J, et al. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J 2002;23:869-876.
8. Kini A, Marmur JD, Kini S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention. J Am Coll Cardiol 1999;34:663-671.
9. Eggers KM, Lagerqvist B, Venge P, et al. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007;116:1907-1914.
10. Jeremias A, Kleiman NS, Nassif D, et al. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: Results from the evaluation of drug eluting stents and ischemic events registry. Circulation 2008;118:632-638.
11. Prasad A, Gersh BJ, Bertrand ME, et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: An analysis from the ACUITY (acute catheterization and urgent intervention triage strategy) trial. J Am Coll Cardiol 2009;54:477-486.
12. Prasad A, Rihal CS, Lennon RJ, et al. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: An analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Intervent 2008;1:10-19.
13. Cavallini C, Verdecchia P, Savonitto S, et al. Prognostic value of isolated troponin I elevation after percutaneous coronary intervention. Circ Cardiovasc Intervent 2010;3:431-435.
14. Ambale-Venkatesh B, Lima JAC. Cardiac MRI: A central prognostic tool in myocardial fibrosis. Nat Rev Cardiol 2015;12:18-29.
15. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet 2003;361:374-379.
16. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772.
17. Ibrahim T, Bulow HP, Hackl T, et al. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol 2007;49:208-216.
18. Moon JCC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-2264.
19. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780-2783.
20. Hueb W, Gersh BJ, Rezende PC, et al. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V trial. BMC Cardiovasc Disord 2012;12:65.
21. Hudsmith LE, Petersen SE, Francis JM, et al. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 2005;7:775-782.
22. Rautaharju PM, Calhoun HP, Chaitman BR. NOVACODE serial ECG classification system for clinical trials and epidemiologic studies. J Electrocardiol 1992;24:179-187.
23. Crow RS, Prineas RJ, Jacobs DR, et al. A new epidemiologic classification system for interim myocardial infarction from serial electrocardiographic changes. Am J Cardiol 1989;64:454-461.
24. Cavallini C, Savonitto S, Violini R, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: Results of the CK-MB and PCI study. Eur Heart J 2005; 26:1494-1498.
25. Novack V, Pencina M, Cohen DJ, et al. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med 2012;172:502-508.
26. Kim RJ, Albert TSE, Wible JH, et al. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: An international, multicenter, double-blinded, randomized trial. Circulation 2008;117:629-637.
27. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-28.
28. Dall'Armellina E, Piechnik SK, Ferreira VM, et al. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson 2012;14:15.
29. Messroghli DR, Walters K, Plein S, et al. Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007;58:34-40.
30. Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2013;6:488-497.
31. Dall'Armellina E, Karia N, Lindsay AC, et al. Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging 2011;4:228-236.
32. Nijveldt R, Beek AM, Hofman MB, et al. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction. J Cardiovasc Magn Reson 2007;9:765-770.
33. Agewall S, Giannitsis E, Jernberg T, et al. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 2010;32:404-411.
34. Gresslien T, Agewall S. Troponin and exercise. Int J Cardiol 2016;221:609-621.
35. Apple FS, Smith SW, Pearce LA, et al. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008;54:723-728.
36. Redfearn DP, Ratib K, Marshall HJ, et al. Supraventricular tachycardia promotes release of troponin I in patients with normal coronary arteries. Int J Cardiol 2005;102:521-522.
37. Turer AT, Addo TA, Martin JL, et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J Am Coll Cardiol 2011;57:2398-2405.
38. Rahimi K, Banning AP, Cheng ASH, et al. Prognostic value of coronary revascularisation-related myocardial injury: A cardiac magnetic resonance imaging study. Heart 2009;95:1937-1943.
|
Language: | English.
|
Document Type: | Coronary Artery Disease.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 1522-1946
|
DOI Number: | https://dx.doi.org/10.1002/ccd.2...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|